Secondly, FGF10 treatment in vivo decreased neuronal apoptosis and inhibited NF-κB signaling activation during ischemic stroke and thereby neuroinflammation (TNF-α and IL-6 production). The gene discussed is IL6; the disease is ischemic stroke.